Safety and efficacy of velpatasvir and sofosbuvir-based regimens for the treatment of HCV genotype 1-6: Results of the HCV-target study

Authors
Category Primary study
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: a263a0d7fcea4f2f4562a53abbbbb4b3f372d20b
First added on: Feb 08, 2025